TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Success rate of delivery of the ambulatory pleruodesis protocol
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Brunnstrom Hand Manipulation (BRS-H)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative change in urine NGAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Perioperative change in serum NGAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cervical Range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of left atrial volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of overexpression of STARD3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Index segment revision
Endpoint domain: Adverse events/effects
Primary endpoint: Knee flexion angle during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip flexion angle during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum foot clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Score of Quality of Life Enjoyment & Satisfaction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reversal of Respiratory Depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Allergy to Study Compounds
Endpoint domain: Adverse events/effects
Primary endpoint: Hand length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross grip strength measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremity functional status assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Anatomical variants of paranasal sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCT scans score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway-secretion removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fistula Cannulation Related Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety at Six Sessions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to death or lung transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Time to first clinical worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of clinical worsenings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-39 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Papilla cannulation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOS 36-Item Short-Form Health Survey (SF36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Partner In Health scale (PIH)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to UTI antibiotic initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in multi-system symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in functional health and well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change In Post Operative Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oral Morphine Equivalence (OME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite VOR gain (cVOR gain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative acute renal injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hand strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Activities of Daily Living (ADLs)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tissue Biomechanical Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pelvic floor muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MRI assessment of bladder wall penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg girth measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of C difficile associated diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Participation of Daily Life PODCI Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: social impact of pediatric liver transplantation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Acceptability of the rehabilitation program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the rehabilitation program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Huntington's Disease Cognitive Assessment Battery (HD-CAB) Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expressive One Word Picture Vocabulary Test-Fourth Edition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Receptive One Word Picture Vocabulary Test-Fourth Edition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Child Language Sample
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: MacArthur-Bates Communicative Development Inventory - Computer Adaptive Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in presence of antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Blood oxygen level-dependent (BOLD) signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct diagnosis of PAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24-hour blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants cured from urinary tract infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of High-Intensity Statin Prescription at discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of High-Intensity Statin Prescription at 90 days post-discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Pelvic Floor Health Knowledge Test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Completion rate of clinical outcome measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in rate of screening completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in time to screening completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ASPECTS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palatal donor site healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Residual myometrium thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of radioactive dose excreted in urine and feces after IV administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of radioactive dose excreted in urine and feces after oral administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Pharmacokinetic (PK) parameter: AUC for radioactivity and SAR439859 after IV administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) from time 0 to the last quantifiable concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal voluntary contraction (knee extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Broad Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soreness scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Fine motor skill dexterity test (9HPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total anesthetic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of fetal cells recovered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of DNA data on each cell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of grade ≥ 4 esophageal adverse events within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: rate of grade ≥ 4 esophageal adverse events within 84 days
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: AUC0-12,ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid consumption (mg)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Montreal Cognitive Assessment test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Short form survey-12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IL-6 salival levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF-α salival levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Leptin salival levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adiponectin salival levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin salival levels with elisa test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of CSF leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Dual-task gait performance: Stride length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual-task gait performance: Double limb support time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive function - Inhibition control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive function - Shifting attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive function - Working memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FVC (mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Decolonization of Multidrug-Resistant Organisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinically Significant Event (CSE)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Health Questionnaire-9 Item Version
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Revised Child Anxiety and Depression Scale (RCADS-25)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity of Montreal Cognitive Assessment score < 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with major toxicities of at least CTCAE Grade 3 and above
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with minor toxicities of CTCAE Grade 1 and 2
Endpoint domain: Adverse events/effects
Primary endpoint: Length of hospitalisation stay for each PIPAC procedure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Muscle Strength of Trunk Flexion / Extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle Electromyographic Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis related to IL4I1+ cells
Endpoint domain: Mortality/survival
Primary endpoint: Response to treatments (targeted and/or antiPD1/CTLA4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percentage of AKI in COVID-19 in diabetic patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of major congenital malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lower limb muscle power after Five Times Sit to Stand Test (5STS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent confirmed multiple beta-cell autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in asthma control test (ACT) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in the LPPAI score from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hair growth from baseline to study completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychosocial distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score of MDS Unified-Parkinson Disease Rating Scale III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Rate of participant enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of appropriate study drug administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of participant retention to 90-day follow up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Wijma Birth Anticipation/Experience Scale A (W-DEQ-A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HBsAg clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: composite of major adverse events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: changes of Hba1c from baseline at 6 months post procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: UTI episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Social and psychological impacts of containment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in grief levels at 10 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in grief levels at 20 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive depletion
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mental and Physical Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time Up & Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monopodalic CMJ (countermovement jump test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score of the National Institutes of Health Chronic Prostatitis Symptom Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in red cell omega-3 index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of bone marrow undetectable minimal residual disease (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: T1ρ relaxation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with grade 1-3 oxaliplatin-induced peripheral neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-thawing Ovarian Follicle morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Compliance to the Bowel Preparation Protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tolerance to the Bowel Preparation Protocol
Endpoint domain: Adverse events/effects
Primary endpoint: Number of pumping sessions per day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Progression-free survival rate at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Relapse-free survival rate at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of abnormal clinical laboratory findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chipping rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum knee extension repetitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documentation of Advance Care Planning Discussions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of Dose-Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of pediatric population seropositive for yellow fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: anxiety features
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal urinary excretion level of dialkylphosphates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Senior Fitness Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histologic Response Scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGM glucose outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Grade 3 or Higher Treatment Related Treatment Emergent-Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Daily Drinking Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Young Adult Alcohol Consequences Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Daily Marijuana Use Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depression measured by Hospital Anxiety and Depression Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Engagement with the text-messaging program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Acceptability at 1 month
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of Nurses' in the management of upper GI bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Practice of Nurses' in the management of upper GI bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in clinician-rated symptom severity between baseline and follow-ups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in self-reported symptom severity between baseline and follow-ups
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in clinician-rated social-role functioning between baseline and follow-ups
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in IBD-related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ecological Momentary Intervention Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Baseline depressive symptom
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-intervention depressive symptom
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lupus anticoagulant test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of chronic thrombo-embolic disease (CTED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Occurrence of P. falciparum parasitemia assessed by PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Parasite density dynamics assessed by PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Disability change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Infertility Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infertility Self-Efficacy Scale-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status